AK001

lirentelimab · Allakos

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AK001, covering 2016-06-29 to 2016-06-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK001 [Phase 1]